GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 873 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 51-59 of 59 matching filings.

Per page
25
Current page
3
10-Q File 000-08092

OXIS QUARTERLY REPORT

Filing date
20 Aug 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

OXIS 10-Q MARCH 31, 2012

Filing date
21 May 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
10-Q File 000-08092

OXIS QUARTERLY REPORT SEPT 30, 2011

Filing date
21 Nov 2011
Reporting date
30 Sep 2011
Next action
Verify source filing
10-Q/A File 000-08092

OXIS QUARTERLY REPORT JUNE 30, 2011 AMENDED

Filing date
12 Sep 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 000-08092

OXIS QUARTERLY REPORT JUNE 30, 2011

Filing date
22 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

OXIS FORM 10-Q 3-31-11

Filing date
16 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

OXIS FORM 10-Q 9-30-2010

Filing date
12 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

OXIS FORM 10-Q 6-30-10

Filing date
16 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

OXIS FORM 10-Q 3-31-10

Filing date
14 May 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .